Sign up
Pharma Capital

UK RNS Announcements

Date Provider Announcement
13/07/2018 Thomson Reuters End of Day Message
13/07/2018 London Stock Exchange Final Announcement Released
13/07/2018 Business Wire End of Day Message
13/07/2018 PR Newswire PR Newswire - End of Day
13/07/2018 XLON:NXG Form 8.5 (EPT/RI) - Amendment
13/07/2018 XLON:CYBG Form 8.5 (EPT/RI) - Amendment
13/07/2018 XLON:0RN3,XLON:BARC Form 8.3 - TAKEDA PHARMACEUTICAL CO LTD - Amendment
13/07/2018 XLON:SHP,XLON:BARC Form 8.3 - SHIRE PLC - Amendment
13/07/2018 XLON:VED,XLON:BARC Form 8.3 - VEDANTA RESOURCES - Amendment
13/07/2018 LSE:0HR2 Form 8.5 (EPT/RI) - Amendment
13/07/2018 LSE:0HR2 Form 8.5 (EPT/RI) - Amendment
13/07/2018 LSE:34GV Publication of Final Terms
13/07/2018 XLON:VM. Form 8.5 (EPT/RI) - Amendment
13/07/2018 XLON:VM. Form 8.5 (EPT/RI) - Amendment
13/07/2018 XLON:CYBG Form 8.5 (EPT/RI) - Amendment
13/07/2018 LSE:IAG Transaction in Own Shares
13/07/2018 XLON:NXG Form 8.5 (EPT/RI) - Amendment
13/07/2018 XLON:CYBG Form 8.5 (EPT/RI) - Amendment
13/07/2018 LSE:49QW Financial Statements of the Guarantor
13/07/2018 LSE:NBDD,XLON:NBDX,XLON:NBDG Net Asset Value(s)
13/07/2018 LSE:AEFS Net Asset Value(s)
13/07/2018 LSE:NBLS,XLON:NBLU Net Asset Value(s)
13/07/2018 LSE:RIO Transaction in Own Shares
13/07/2018 LSE:DLAR Director/PDMR Shareholding
13/07/2018 LSE:DLAR Director/PDMR Shareholding

© biotech Capital 2018

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.